Company intelligence / Profile preview
AJNA BioSciences
Littleton, Colorado, United Statesajnabiosciences.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
The company’s lead candidate AJA001 completed a Phase 1 single and multiple ascending dose trial demonstrating safety and tolerability in ASD patients. The formulation was optimized for ASD presentation. Results were presented at the American College of Neuropsychopharmacology in December 2024.[3]
- Therapeutic areas
- Psychiatry
- Modalities
- Botanical drugs (multi-cannabinoid botanical drug products)Plant-derived pharmaceuticals[1][3]Fungi-derived pharmaceuticals[3]
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Charlotte's Web – joint venture partner via DeFloria for cannabinoid-based therapies.[3]
Beyond the preview
Go deeper on AJNA BioSciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on AJNA BioSciences.